11:06 AM EDT, 08/07/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were trending higher late Wednesday morning, rising 0.86% to 1,385.30 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by internet browser company Opera (OPRA) and biotech firm Evaxion Biotech ( EVAX ) , which climbed 9.5% and 8%, respectively. They were followed by biopharmaceutical companies Genfit ( GNFT ) and DBV Technologies ( DBVT ) , which rose 6.9% and 5.6%, respectively.

The decliners from continental Europe were led by pharmaceutical company Novo Nordisk ( NVO ) and semiconductor company Sequans Communications ( SQNS ) , which fell 6.3% and 6.2%, respectively. They were followed by accommodations booking company trivago (TRVG) and biopharmaceutical company Cellectis ( CLLS ) , which lost 1% each.

From the UK and Ireland, the gainers were led by biotech firm Trinity Biotech ( TRIB ) and telecommunications operator Vodafone Group ( VOD ) , which increased 4.9% and 4.3%, respectively. They were followed by biopharmaceutical company Adaptimmune Therapeutics ( ADAP ) and Prudential (PUK), which were up 4% and 3.2%, respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies TC Biopharm ( TCBP ) and Bicycle Therapeutics ( BCYC ) , which dropped 7.2% and 3.6%, respectively. They were followed by biopharmaceutical companies Amarin ( AMRN ) and Mereo BioPharma Group ( MREO ) , which were down 2.5% and 2.3%, respectively.